Nuvation Bio Inc.
NYSENuvation Bio heads into its May 8 earnings report with short sellers making a clear statement — and options traders ignoring them entirely. Short interest has become the dominant feature of the positioning picture. At roughly 22% of the free float, it has climbed for four consecutive weeks, rising about 6% over the past week alone and nearly 8.5% over the past month. The ORTEX…
Snapshot as of 7 May 2026
Nuvation Bio heads into its May 8 earnings report with short sellers making a clear statement — and options traders ignoring them entirely. Short interest has become the dominant feature of the positioning picture. At…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NUVB — free to start on ORTEX.
Sign up for free →Open NUVB on ORTEX